强度调製放射治疗市场－全球产业规模、份额、趋势、机会和预测，按放射类型、应用、最终用户、地区和竞争格局划分，2020-2030年预测

2024年全球调强放射治疗市场规模为20.1亿美元，预计2030年将以5.61%的复合年增长率成长至27.9亿美元。调强放射治疗（IMRT）是一种先进的放射治疗技术，它透过调节众多细小放射束的强度，将辐射精确地输送到肿瘤部位，从而贴合肿瘤形状并最大限度地减少对周围健康组织的辐射暴露。该市场的成长主要受全球各类癌症发病率上升以及人们对更有效、毒性更小的治疗方式（旨在提高患者生活品质）的需求不断增长的驱动。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：客户之声

第五章：全球调强放射治疗市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依辐射类型（质子辐射、电子辐射、光子辐射、碳离子辐射）
  • 按最终使用者（医院和诊所、门诊手术护理、其他）
  • 依应用领域（前列腺癌、肺癌、乳癌、脑癌、妇科癌症、胃肠道癌症、其他癌症）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美调强放射治疗市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲调强放射治疗市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区调强放射治疗市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东与非洲调强放射治疗市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲调强放射治疗市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新进展

第十三章：全球调强放射治疗市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Siemens Healthineers AG
• Accuray Incorporated
• Elekta GmbH
• Iba LLC
• Hitachi, Ltd.
• Mevion Medical Systems BV
• Koninklijke Philips NV
• Raysearch Laboratories AB
• Brainlab AG
• HD Biosciences Co., Ltd.

第十六章：策略建议

第17章调查会社について・免责事项

The Global Intensity Modulated Radiotherapy Market, valued at USD 2.01 Billion in 2024, is projected to experience a CAGR of 5.61% to reach USD 2.79 Billion by 2030. Intensity Modulated Radiotherapy (IMRT) is an advanced radiation therapy technique that precisely delivers radiation to tumors by modulating the intensity of numerous small radiation beams, thereby conforming to the tumor shape and minimizing exposure to surrounding healthy tissues. The market's expansion is fundamentally driven by the escalating global incidence of various cancer types, coupled with increasing demand for effective and less toxic treatment modalities that improve patient quality of life.

Key Market Drivers

The global Intensity Modulated Radiotherapy market is significantly influenced by the escalating global incidence of cancer, which fundamentally drives the demand for advanced and precise treatment modalities. The rising number of new cancer diagnoses worldwide necessitates effective therapeutic options like IMRT to manage the growing patient population. According to the American Cancer Society, in April 2024, in its "Global Cancer Statistics, 2024" report, an estimated 20 million cancer cases were newly diagnosed in 2022, underscoring the substantial and expanding need for oncology services.

Key Market Challenges

The significant capital investment required for Intensity Modulated Radiotherapy (IMRT) equipment acquisition, installation, and ongoing maintenance directly impedes the growth of the global market. This substantial financial outlay creates a considerable barrier, especially for healthcare providers in developing economies where budgets are frequently constrained. The high initial purchase price of sophisticated IMRT systems, coupled with expenses for specialized facility infrastructure, comprehensive training for technical staff, and continuous servicing contracts, places a heavy burden on healthcare systems.

Key Market Trends

The shift towards hypofractionated Intensity Modulated Radiotherapy regimens represents a significant trend in the global market, driven by its ability to deliver higher radiation doses per fraction over a shorter treatment period. This approach enhances patient convenience by reducing the number of hospital visits and overall treatment duration, while potentially lowering healthcare costs and improving access to care. According to an ASTRO 2024 report, approximately 7% of patients with intermediate-risk prostate cancer in the U. S. received hypofractionated regimens, indicating a substantial adoption rate in this patient cohort. This widespread acceptance is further supported by clinical evidence.

Key Market Players

• Siemens Healthineers AG
• Accuray Incorporated
• Elekta GmbH
• Iba LLC
• Hitachi, Ltd.
• Mevion Medical Systems B.V.
• Koninklijke Philips N.V.
• Raysearch Laboratories AB
• Brainlab AG
• HD Biosciences Co., Ltd.

Report Scope:

In this report, the Global Intensity Modulated Radiotherapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Intensity Modulated Radiotherapy Market, By Radiation Type:

• Proton radiation
• Electron radiation
• Photon radiation
• Carbon-lon radiation

Intensity Modulated Radiotherapy Market, By End User:

• Hospital & Clinics
• Ambulatory Surgical care
• Others

Intensity Modulated Radiotherapy Market, By Application:

• Prostate cancer
• Lung cancer
• Breast cancer
• Brain cancer
• Gynecological cancers
• Gastrointestinal cancers
• Other cancers

Intensity Modulated Radiotherapy Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Intensity Modulated Radiotherapy Market.

Available Customizations:

Global Intensity Modulated Radiotherapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Intensity Modulated Radiotherapy Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Radiation Type (Proton radiation, Electron radiation, Photon radiation, Carbon-lon radiation)
  • 5.2.2. By End User (Hospital & Clinics, Ambulatory Surgical care, Others)
  • 5.2.3. By Application (Prostate cancer, Lung cancer, Breast cancer, Brain cancer, Gynecological cancers, Gastrointestinal cancers, Other cancers)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Intensity Modulated Radiotherapy Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Radiation Type
  • 6.2.2. By End User
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Intensity Modulated Radiotherapy Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Radiation Type
      • 6.3.1.2.2. By End User
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Intensity Modulated Radiotherapy Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Radiation Type
      • 6.3.2.2.2. By End User
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Intensity Modulated Radiotherapy Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Radiation Type
      • 6.3.3.2.2. By End User
      • 6.3.3.2.3. By Application

7. Europe Intensity Modulated Radiotherapy Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Radiation Type
  • 7.2.2. By End User
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Intensity Modulated Radiotherapy Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Radiation Type
      • 7.3.1.2.2. By End User
      • 7.3.1.2.3. By Application
  • 7.3.2. France Intensity Modulated Radiotherapy Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Radiation Type
      • 7.3.2.2.2. By End User
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Intensity Modulated Radiotherapy Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Radiation Type
      • 7.3.3.2.2. By End User
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Intensity Modulated Radiotherapy Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Radiation Type
      • 7.3.4.2.2. By End User
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Intensity Modulated Radiotherapy Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Radiation Type
      • 7.3.5.2.2. By End User
      • 7.3.5.2.3. By Application

8. Asia Pacific Intensity Modulated Radiotherapy Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Radiation Type
  • 8.2.2. By End User
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Intensity Modulated Radiotherapy Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Radiation Type
      • 8.3.1.2.2. By End User
      • 8.3.1.2.3. By Application
  • 8.3.2. India Intensity Modulated Radiotherapy Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Radiation Type
      • 8.3.2.2.2. By End User
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Intensity Modulated Radiotherapy Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Radiation Type
      • 8.3.3.2.2. By End User
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Intensity Modulated Radiotherapy Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Radiation Type
      • 8.3.4.2.2. By End User
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Intensity Modulated Radiotherapy Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Radiation Type
      • 8.3.5.2.2. By End User
      • 8.3.5.2.3. By Application

9. Middle East & Africa Intensity Modulated Radiotherapy Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Radiation Type
  • 9.2.2. By End User
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Intensity Modulated Radiotherapy Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Radiation Type
      • 9.3.1.2.2. By End User
      • 9.3.1.2.3. By Application
  • 9.3.2. UAE Intensity Modulated Radiotherapy Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Radiation Type
      • 9.3.2.2.2. By End User
      • 9.3.2.2.3. By Application
  • 9.3.3. South Africa Intensity Modulated Radiotherapy Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Radiation Type
      • 9.3.3.2.2. By End User
      • 9.3.3.2.3. By Application

10. South America Intensity Modulated Radiotherapy Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Radiation Type
  • 10.2.2. By End User
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Intensity Modulated Radiotherapy Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Radiation Type
      • 10.3.1.2.2. By End User
      • 10.3.1.2.3. By Application
  • 10.3.2. Colombia Intensity Modulated Radiotherapy Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Radiation Type
      • 10.3.2.2.2. By End User
      • 10.3.2.2.3. By Application
  • 10.3.3. Argentina Intensity Modulated Radiotherapy Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Radiation Type
      • 10.3.3.2.2. By End User
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Intensity Modulated Radiotherapy Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Siemens Healthineers AG
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Accuray Incorporated
• 15.3. Elekta GmbH
• 15.4. Iba LLC
• 15.5. Hitachi, Ltd.
• 15.6. Mevion Medical Systems B.V.
• 15.7. Koninklijke Philips N.V.
• 15.8. Raysearch Laboratories AB
• 15.9. Brainlab AG
• 15.10. HD Biosciences Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer